AXSM: Axsome Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-27 | 13G amendment | BlackRock, Inc. | 5.30% | SEC |
Institutional ownership (Q2 2026)
507 institutions reported holding $9.20B of Axsome Therapeutics, Inc. on Form 13F (412 the quarter before). 130 opened a new position and 40 sold out. Shares held by institutions: +2%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 3,103,708 | $759.69M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,983,514 | $485.50M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,965,086 | $480.99M |
| Invesco Ltd. | 1,671,684 | $409.18M |
| FMR LLC | 1,539,163 | $376.74M |
| GEODE CAPITAL MANAGEMENT, LLC | 967,172 | $236.79M |
| Assenagon Asset Management S.A. | 909,364 | $222.59M |
| MORGAN STANLEY | 804,082 | $196.82M |
| STATE STREET CORP | 785,661 | $192.29M |
| Deep Track Capital, LP | 700,000 | $171.34M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.